Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Links relacionados
Similares en SciELO
Compartir
Medicina (Buenos Aires)
versión impresa ISSN 0025-7680versión On-line ISSN 1669-9106
Resumen
FUENTE, Graciela V et al. Insulinización en la diabetes mellitus tipo 2: Alternativas de intensificación. Medicina (B. Aires) [online]. 2016, vol.76, n.3, pp.173-179. ISSN 0025-7680.
Diabetes mellitus is associated with vascular complications and high rates of morbidity and mortality. Timely insulin therapy, intensified when necessary, represent appropriate measures to prevent or delay the onset of complications. However, the incidence of hypoglycemia and difficulties in treatment adherence represent barriers to achieve therapeutic success. Premixes analogs and, specially, combinations of insulin analogues are associated with pharmacokinetic and pharmacodynamic advantages, that translate into clinical benefits such as improved metabolic control, decreased hypoglycemic events and, for their simplicity, potentially greater adherence.
Palabras clave : Insulin; Combination drugs; Aspart insulin; Degludec insulin; Insulin-therapy; Biphasic insulin.